41 results on '"Nieveen van Dijkum, E J M"'
Search Results
2. Thyroid Lobectomy for Low-Risk 1–4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up
- Author
-
Lin, J. F., Rodriguez Schaap, P. M., Metman, M. J. H., Nieveen van Dijkum, E. J. M., Dickhoff, C., Links, T. P., Kruijff, S., and Engelsman, A. F.
- Published
- 2023
- Full Text
- View/download PDF
3. Neuro-endocriene tumoren
- Author
-
Engelsman, A. F., Nieveen van Dijkum, E. J. M., van Eijck, C. H. J., Heineman, E., editor, Heineman, D.J., editor, Lange jr., J.F.M., editor, Blankensteijn, J.D., editor, Boermeester, M.A., editor, Borel Rinkes, I.H.M., editor, Klaase, J.M., editor, Schipper, I.B., editor, Schreurs, W.H., editor, and Wijnen, R.M.H., editor
- Published
- 2021
- Full Text
- View/download PDF
4. Implementing structured team debriefing using a Black Box in the operating room: surveying team satisfaction
- Author
-
van Dalen, A. S. H. M., Jansen, M., van Haperen, M., van Dieren, S., Buskens, C. J., Nieveen van Dijkum, E. J. M., Bemelman, W. A., Grantcharov, T. P., and Schijven, M. P.
- Published
- 2021
- Full Text
- View/download PDF
5. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
- Author
-
Genç, C. G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klümpen, H. J., van Eijck, C. H. J., and Nieveen van Dijkum, E. J. M.
- Published
- 2018
- Full Text
- View/download PDF
6. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands
- Author
-
Genc, C. G., Klümpen, H. J., van Oijen, M. G. H., van Eijck, C. H. J., and Nieveen van Dijkum, E. J. M.
- Published
- 2017
- Full Text
- View/download PDF
7. Thyroid Lobectomy for Low-Risk 1–4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up
- Author
-
Lin, J. F., primary, Rodriguez Schaap, P. M., additional, Metman, M. J. H., additional, Nieveen van Dijkum, E. J. M., additional, Dickhoff, C., additional, Links, T. P., additional, Kruijff, S., additional, and Engelsman, A. F., additional
- Published
- 2022
- Full Text
- View/download PDF
8. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors
- Author
-
Heidsma, Charlotte M, van Roessel, Stijn, van Dieren, Susan, Engelsman, Anton F, Strobel, Oliver, Buechler, Markus W, Schimmack, Simon, Perinel, Julie, Adham, Mustapha, Deshpande, Vikram, Kjaer, Josefine, Norlén, Olov, Gill, Anthony J, Samra, Jaswinder S, Mittal, Anubhav, Hoogwater, Frederik J H, Primavesi, Florian, Stättner, Stefan, Besselink, Marc G, van Eijck, Casper H J, Nieveen van Dijkum, E J M, Heidsma, Charlotte M, van Roessel, Stijn, van Dieren, Susan, Engelsman, Anton F, Strobel, Oliver, Buechler, Markus W, Schimmack, Simon, Perinel, Julie, Adham, Mustapha, Deshpande, Vikram, Kjaer, Josefine, Norlén, Olov, Gill, Anthony J, Samra, Jaswinder S, Mittal, Anubhav, Hoogwater, Frederik J H, Primavesi, Florian, Stättner, Stefan, Besselink, Marc G, van Eijck, Casper H J, and Nieveen van Dijkum, E J M
- Abstract
BACKGROUND: Despite the low recurrence rate of resected nonfunctional pancreatic neuroendocrine tumors (NF-pNETs), nearly all patients undergo long-term surveillance. A prediction model for recurrence may help select patients for less intensive surveillance or identify patients for adjuvant therapy. The objective of this study was to assess the external validity of a recently published model predicting recurrence within 5 years after surgery for NF-pNET in an international cohort. This prediction model includes tumor grade, lymph node status and perineural invasion as predictors. METHODS: Retrospectively, data were collected from 7 international referral centers on patients who underwent resection for a grade 1-2 NF-pNET between 1992 and 2018. Model performance was evaluated by calibration statistics, Harrel's C-statistic, and area under the curve (AUC) of the receiver operating characteristic curve for 5-year recurrence-free survival (RFS). A sub-analysis was performed in pNETs >2 cm. The model was improved to stratify patients into 3 risk groups (low, medium, high) for recurrence. RESULTS: Overall, 342 patients were included in the validation cohort with a 5-year RFS of 83% (95% confidence interval [CI]: 78-88%). Fifty-eight patients (17%) developed a recurrence. Calibration showed an intercept of 0 and a slope of 0.74. The C-statistic was 0.77 (95% CI: 0.70-0.83), and the AUC for the prediction of 5-year RFS was 0.74. The prediction model had a better performance in tumors >2 cm (C-statistic 0.80). CONCLUSIONS: External validity of this prediction model for recurrence after curative surgery for grade 1-2 NF-pNET showed accurate overall performance using 3 easily accessible parameters. This model is available via www.pancreascalculator.com.
- Published
- 2022
- Full Text
- View/download PDF
9. Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome
- Author
-
Utrecht Valorisatie Centrum, Endocrinologie onderzoek, Genetica, MS Neonatologie, Arts-assistenten Radiologie, Other research (not in main researchprogram), PMC Medisch specialisten, Endocrinologie patientenzorg, Brain, Child Health, Cancer, Jonker, L A, Lebbink, C A, Jongmans, M C J, Nievelstein, R A J, Merks, J H M, Nieveen van Dijkum, E J M, Links, T P, Hoogerbrugge, N, van Trotsenburg, A S P, van Santen, H M, Utrecht Valorisatie Centrum, Endocrinologie onderzoek, Genetica, MS Neonatologie, Arts-assistenten Radiologie, Other research (not in main researchprogram), PMC Medisch specialisten, Endocrinologie patientenzorg, Brain, Child Health, Cancer, Jonker, L A, Lebbink, C A, Jongmans, M C J, Nievelstein, R A J, Merks, J H M, Nieveen van Dijkum, E J M, Links, T P, Hoogerbrugge, N, van Trotsenburg, A S P, and van Santen, H M
- Published
- 2020
10. Hemithyroidectomy versus total thyroidectomy for well differentiated T1–2 N0 thyroid cancer: systematic review and meta-analysis
- Author
-
Rodriguez Schaap, P M, primary, Botti, M, additional, Otten, R H J, additional, Dreijerink, K M A, additional, Nieveen van Dijkum, E J M, additional, Bonjer, H J, additional, Engelsman, A F, additional, and Dickhoff, C, additional
- Published
- 2020
- Full Text
- View/download PDF
11. New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands
- Author
-
Lebbink, C A, primary, Dekker, B L, additional, Bocca, G, additional, Braat, A J A T, additional, Derikx, J P M, additional, Dierselhuis, M P, additional, de Keizer, B, additional, Kruijff, S, additional, Kwast, A B G, additional, van Nederveen, F H, additional, Nieveen van Dijkum, E J M, additional, Nievelstein, R A J, additional, Peeters, R P, additional, Terwisscha van Scheltinga, C E J, additional, Tissing, W J E, additional, van der Tuin, K, additional, Vriens, M R, additional, Zsiros, J, additional, van Trotsenburg, A S P, additional, Links, T P, additional, and van Santen, H M, additional
- Published
- 2020
- Full Text
- View/download PDF
12. Implementing structured team debriefing using a Black Box in the operating room: surveying team satisfaction
- Author
-
van Dalen, A. S. H. M., primary, Jansen, M., additional, van Haperen, M., additional, van Dieren, S., additional, Buskens, C. J., additional, Nieveen van Dijkum, E. J. M., additional, Bemelman, W. A., additional, Grantcharov, T. P., additional, and Schijven, M. P., additional
- Published
- 2020
- Full Text
- View/download PDF
13. Laparoscopic ultrasonography for abdominal tumor staging
- Author
-
van Delden, O. M., de Wit, L. T., Nieveen van Dijkum, E. J. M., Reeders, J. W. A. J., and Gouma, D. J.
- Published
- 1998
- Full Text
- View/download PDF
14. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators’ consensus criteria within a worldwide cohort of patients
- Author
-
Vorselaars, W. M. C. M., van Beek, D. -J., Postma, E. L., Spiering, W., Borel Rinkes, I. H. M., Valk, G. D., Vriens, M. R., Zarnegar, R., Drake, F. T., Duh, Q. Y., Talutis, S. D., Mcaneny, D. B., Mcmanus, C., Lee, J. A., Grant, S. B., Grogan, R. H., Romero Arenas, M. A., Perrier, N. D., Peipert, B. J., Mongelli, M. N., Castelino, T., Mitmaker, E. J., Parente, D. N., Pasternak, J. D., Engelsman, A. F., Sywak, M., D'Amato, Giuseppe, Raffaelli, Marco, Schuermans, V., Bouvy, N. D., Eker, H. H., Bonjer, H. J., Vaarzon Morel, N. M., Nieveen van Dijkum, E. J. M., Metman, M. J. H., Kruijff, S., D'Amato G., Raffaelli M. (ORCID:0000-0002-1259-2491), Vorselaars, W. M. C. M., van Beek, D. -J., Postma, E. L., Spiering, W., Borel Rinkes, I. H. M., Valk, G. D., Vriens, M. R., Zarnegar, R., Drake, F. T., Duh, Q. Y., Talutis, S. D., Mcaneny, D. B., Mcmanus, C., Lee, J. A., Grant, S. B., Grogan, R. H., Romero Arenas, M. A., Perrier, N. D., Peipert, B. J., Mongelli, M. N., Castelino, T., Mitmaker, E. J., Parente, D. N., Pasternak, J. D., Engelsman, A. F., Sywak, M., D'Amato, Giuseppe, Raffaelli, Marco, Schuermans, V., Bouvy, N. D., Eker, H. H., Bonjer, H. J., Vaarzon Morel, N. M., Nieveen van Dijkum, E. J. M., Metman, M. J. H., Kruijff, S., D'Amato G., and Raffaelli M. (ORCID:0000-0002-1259-2491)
- Abstract
Background: In a first step toward standardization, the Primary Aldosteronism Surgical Outcomes investigators introduced consensus criteria defining the clinical outcomes after adrenalectomy for primary aldosteronism. Within this retrospective cohort study, we evaluated the use of these consensus criteria in daily clinical practice in 16 centers in Europe, Canada, Australia, and the United States. Methods: Patients who underwent unilateral adrenalectomy for primary aldosteronism between 2010 and 2016 were included. Patients with missing data regarding preoperative or postoperative blood pressure or their defined daily dose were excluded. According to the Primary Aldosteronism Surgical Outcomes criteria, patients were classified as complete, partial, or absent clinical success. Results: A total of 380 patients were eligible for analysis. Complete, partial, and absent clinical success was achieved in 30%, 48%, and 22%, respectively. Evaluation of the Primary Aldosteronism Surgical Outcomes criteria showed that in 11% and 47% of patients with partial and absent clinical success, this classification was incorrect or debatable (16% of the total cohort). This concept of a “debatable classification of success” was due mainly to the cutoff of ≥20 mmHg used to indicate a clinically relevant change in systolic blood pressure and the use of percentages instead of absolute values to indicate a change in defined daily dose. Conclusion: Although introduction of the Primary Aldosteronism Surgical Outcomes consensus criteria induced substantial advancement in the standardization of postoperative outcomes, our study suggests that there is room for improvement in the concept for success given the observed limitations when the criteria were tested within our international cohort. In line, determining clinical success remains challenging, especially in patients with opposing change in blood pressure and defined daily dose.
- Published
- 2019
15. Laparoscopic assisted central mesenteric lymph node dissection with bowel sparing resection of small bowel neuroendocrine tumours using fluorescence angiography – a video vignette
- Author
-
Kaçmaz, E., primary, Slooter, M. D., additional, Nieveen van Dijkum, E. J. M., additional, Tanis, P. J., additional, and Engelsman, A. F., additional
- Published
- 2019
- Full Text
- View/download PDF
16. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer : Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
- Author
-
Clement, S C, Kremer, Leontine C M, Verburg, Frederik A., Simmons, J H, Goldfarb, M, Peeters, Robin P, Alexander, E K, Bardi, Edit, Brignardello, E, Constine, Louis S, Dinauer, C A, Drozd, V M, Felicetti, F, Frey, S.E., Heinzel, Andreas, van den Heuvel-Eibrink, M M, Huang, S A, Links, Thera P, Krummel-Lorenz, B, Mulder, Renée L, Neggers, S J, Nieveen van Dijkum, E J M, Oeffinger, Kevin C, van Rijn, R., Rivkees, S A, Ronckers, Cécile M., Schneider, A B, Skinner, R., Wasserman, J D, Wynn, T, Hudson, M., Nathan, P C, van Santen, H M, Clement, S C, Kremer, Leontine C M, Verburg, Frederik A., Simmons, J H, Goldfarb, M, Peeters, Robin P, Alexander, E K, Bardi, Edit, Brignardello, E, Constine, Louis S, Dinauer, C A, Drozd, V M, Felicetti, F, Frey, S.E., Heinzel, Andreas, van den Heuvel-Eibrink, M M, Huang, S A, Links, Thera P, Krummel-Lorenz, B, Mulder, Renée L, Neggers, S J, Nieveen van Dijkum, E J M, Oeffinger, Kevin C, van Rijn, R., Rivkees, S A, Ronckers, Cécile M., Schneider, A B, Skinner, R., Wasserman, J D, Wynn, T, Hudson, M., Nathan, P C, and van Santen, H M
- Published
- 2018
17. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
- Author
-
Endocrinologie onderzoek, Zorg en O&O, PMC Medisch specialisten, Onderzoeksgroep 7, Brain, Endocrinologie patientenzorg, Child Health, Clement, S C, Kremer, Leontine C M, Verburg, Frederik A., Simmons, J H, Goldfarb, M, Peeters, Robin P, Alexander, E K, Bardi, Edit, Brignardello, E, Constine, Louis S, Dinauer, C A, Drozd, V M, Felicetti, F, Frey, S.E., Heinzel, Andreas, van den Heuvel-Eibrink, M M, Huang, S A, Links, Thera P, Krummel-Lorenz, B, Mulder, Renée L, Neggers, S J, Nieveen van Dijkum, E J M, Oeffinger, Kevin C, van Rijn, R., Rivkees, S A, Ronckers, Cécile M., Schneider, A B, Skinner, R., Wasserman, J D, Wynn, T, Hudson, M., Nathan, P C, van Santen, H M, Endocrinologie onderzoek, Zorg en O&O, PMC Medisch specialisten, Onderzoeksgroep 7, Brain, Endocrinologie patientenzorg, Child Health, Clement, S C, Kremer, Leontine C M, Verburg, Frederik A., Simmons, J H, Goldfarb, M, Peeters, Robin P, Alexander, E K, Bardi, Edit, Brignardello, E, Constine, Louis S, Dinauer, C A, Drozd, V M, Felicetti, F, Frey, S.E., Heinzel, Andreas, van den Heuvel-Eibrink, M M, Huang, S A, Links, Thera P, Krummel-Lorenz, B, Mulder, Renée L, Neggers, S J, Nieveen van Dijkum, E J M, Oeffinger, Kevin C, van Rijn, R., Rivkees, S A, Ronckers, Cécile M., Schneider, A B, Skinner, R., Wasserman, J D, Wynn, T, Hudson, M., Nathan, P C, and van Santen, H M
- Published
- 2018
18. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma - A systematic review
- Author
-
Clement, S C, Peeters, R P, Ronckers, C M, Links, T P, van den Heuvel-Eibrink, M M, Nieveen van Dijkum, E J M, van Rijn, R R, van der Pal, H J H, Neggers, S J, Kremer, L C M, van Eck-Smit, B L F, van Santen, H M, Clement, S C, Peeters, R P, Ronckers, C M, Links, T P, van den Heuvel-Eibrink, M M, Nieveen van Dijkum, E J M, van Rijn, R R, van der Pal, H J H, Neggers, S J, Kremer, L C M, van Eck-Smit, B L F, and van Santen, H M
- Published
- 2015
19. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma - A systematic review
- Author
-
Endocrinologie patientenzorg, Child Health, Endocrinologie onderzoek, Clement, S C, Peeters, R P, Ronckers, C M, Links, T P, van den Heuvel-Eibrink, M M, Nieveen van Dijkum, E J M, van Rijn, R R, van der Pal, H J H, Neggers, S J, Kremer, L C M, van Eck-Smit, B L F, van Santen, H M, Endocrinologie patientenzorg, Child Health, Endocrinologie onderzoek, Clement, S C, Peeters, R P, Ronckers, C M, Links, T P, van den Heuvel-Eibrink, M M, Nieveen van Dijkum, E J M, van Rijn, R R, van der Pal, H J H, Neggers, S J, Kremer, L C M, van Eck-Smit, B L F, and van Santen, H M
- Published
- 2015
20. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.
- Author
-
Genc, C. G., Klümpen, H. J., van Oijen, M. G. H., van Eijck, C. H. J., and Nieveen van Dijkum, E. J. M.
- Subjects
TREATMENT effectiveness ,NEUROENDOCRINE tumors ,PANCREATIC tumors ,SURGICAL excision ,TUMOR surgery ,TUMOR treatment - Abstract
Background: Large population-based studies give insight into the prognosis and treatment outcomes of patients with pancreatic neuroendocrine tumors (pNETs). Therefore, we provide an overview of the treatment and related survival of pNET in the Netherlands. Methods: Patients diagnosed with pNET between 2008 and 2013 from the Netherlands Cancer Registry were included. Patient, tumors and treatment characteristics were reported. Survival analyses with log-rank testing were performed to compare survival. Results: In total, 611 patients were included. Median follow-up was 25.7 months, and all-cause mortality was 42%. Higher tumor grade and TNM stage were significantly associated with worse survival in both the overall and metastasized population. The effect of distant metastases on survival was more significant in lower tumor stages (T1-3 p < 0.05, T4 p = 0.074). Resection of the primary tumor was performed in 255 (42%) patients. Patients who underwent surgery had the highest 5-year survival (86%) compared to PRRT (33%), chemotherapy (21%), targeted therapy and somatostatin analogs (24%) (all p < 0.001). Patients with T1M0 tumors ( n = 115) showed favorable survival after surgical resection ( N = 95) compared to no therapy ( N = 20, p = 0.008). Resection also improved survival significantly in patients with metastases compared to other treatments (all p > 0.05). Without surgery, PRRT showed the best survival curves in patients with distant metastases. Grade 3 tumors and surgical resection were independently associated with survival (HR 7.23 and 0.12, respectively). Conclusion: Surgical resection shows favorable outcome for all pNET tumors, including indolent tumors and tumors with distant metastases. Prospective trials should be initiated to confirm these results. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Foutieve 'point-of-care'glucosemeting in een acute situatie
- Author
-
Frasa, M. A. M., Bluggel, Anne, van Dongen - Lases, E. C., Sturk, Augueste, Nieveen van Dijkum, E. J. M., Gouma, D. J., Fischer, J. C., Laboratory for General Clinical Chemistry, Laboratory for Experimental Clinical Chemistry, Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, Other Research, Surgery, and Amsterdam Cardiovascular Sciences
- Published
- 2011
22. Een patiënte met een recidief van hyperparathyreoïdie en een zwelling in de hals
- Author
-
Faneyte, I. F., Sanson, R. E., van Eeden, S., Fliers, E., Gouma, D. J., Nieveen van Dijkum, E. J. M., Pathology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Neuroscience, Endocrinology, Surgery, Cancer Center Amsterdam, and Other Research
- Abstract
72-year-old woman with a history of primary hyperparathyroidism, for which she underwent surgery years previously, went to see her general practitioner because of a swelling in her neck that had been present for a few months and was growing in size. Other than this she had no symptoms. During the physical examination a solid elastic, non-fixed swelling with a diameter of about 3 cm was palpable on the right of the neck, medially to the sternocleidomastoid muscle. The swelling did not move when she swallowed. Laboratory tests and an MRI scan were suggestive of parathyroid carcinoma. An examination of the neck showed a large, irregular, lobed soft tumour and several small deposits with a yellowish brown appearance. Histology showed no characteristics of malignancy, but showed a picture consistent with the diagnosis of 'parathyromatosis', a rare disorder characterized by hormonally active ectopic parathyroid tissue. Treatment is primarily surgical, aimed at radical resection. Medicinal therapy using a calcimimetic agent may have a role as an adjuvant treatment
- Published
- 2009
23. Bijschildklier: adenoom of carcinoom?
- Author
-
Kartashova, M.S., Nieveen van Dijkum, E. J. M., van Eeden, S., Eck-Smit van, B. L. F., Nuclear Medicine, Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, Other Research, Surgery, Pathology, and Amsterdam Cardiovascular Sciences
- Published
- 2008
24. An Adrenal Incidentaloma: How Often Is It Detected and What Are the Consequences?
- Author
-
Minnaar, E. M., primary, Human, K. E., additional, Henneman, D., additional, Nio, C. Y., additional, Bisschop, P. H., additional, and Nieveen van Dijkum, E. J. M., additional
- Published
- 2013
- Full Text
- View/download PDF
25. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma
- Author
-
Nieveen van Dijkum, E J M, primary, Kuhlmann, K F D, additional, Terwee, C B, additional, Obertop, H, additional, de Haes, J C J M, additional, and Gouma, D J, additional
- Published
- 2005
- Full Text
- View/download PDF
26. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma
- Author
-
Nieveen van Dijkum, E J M, primary, Terwee, C B, additional, Oosterveld, P, additional, van der Meulen, J H P, additional, Gouma, D J, additional, and de Haes, J C J M, additional
- Published
- 2000
- Full Text
- View/download PDF
27. A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms
- Author
-
Franz Sellner, Georg Göbel, Daniel Neureiter, Ruben H J de Kleine, Reinhold Függer, Ines Fischer, Elisabeth J. M. Nieveen van Dijkum, Philipp Ellmerer, R. Klug, H. Wundsam, Valentina Andreasi, K. Marsoner, Benno Cardini, Stefan Stättner, Frederik J H Hoogwater, Florian Primavesi, A. Hauer, Charlotte M. Heidsma, Uwe Fröschl, Massimo Falconi, Eckhard Klieser, Tobias Kiesslich, Sabine Thalhammer, Peter Kornprat, Dietmar Öfner, Detlef K. Bartsch, Dominik Wiese, Stefano Partelli, Surgery, AGEM - Digestive immunity, Amsterdam Gastroenterology Endocrinology Metabolism, Primavesi, F., Andreasi, V., Hoogwater, F. J. H., Partelli, S., Wiese, D., Heidsma, C., Cardini, B., Klieser, E., Marsoner, K., Froschl, U., Thalhammer, S., Fischer, I., Gobel, G., Hauer, A., Kiesslich, T., Ellmerer, P., Klug, R., Neureiter, D., Wundsam, H., Sellner, F., Kornprat, P., Fugger, R., Ofner, D., Nieveen van Dijkum, E. J. M., Bartsch, D. K., de Kleine, R. H. J., Falconi, M., and Stattner, S.
- Subjects
Cancer Research ,medicine.medical_specialty ,Survival ,GLASGOW PROGNOSTIC SCORE ,risk score ,SURGICAL COMPLICATIONS ,GUIDELINES ,DIAGNOSIS ,lcsh:RC254-282 ,survival ,Article ,CLASSIFICATION ,C-reactive protein ,surgery ,03 medical and health sciences ,0302 clinical medicine ,PROPOSAL ,Epidemiology ,medicine ,EPIDEMIOLOGY ,pancreas ,Pancreas ,Pancreatic neuroendocrine tumors ,Grading (tumors) ,Framingham Risk Score ,pancreatic neuroendocrine tumors ,biology ,neuroendocrine neoplasms ,business.industry ,Histology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,SYSTEMIC INFLAMMATORY RESPONSE ,EFFICACY ,CANCER ,Surgery ,medicine.anatomical_structure ,Oncology ,Neuroendocrine neoplasms ,030220 oncology & carcinogenesis ,Cohort ,biology.protein ,Risk score ,030211 gastroenterology & hepatology ,business ,Cohort study - Abstract
Background: Oncological survival after resection of pancreatic neuroendocrine neoplasms (panNEN) is highly variable depending on various factors. Risk stratification with preoperatively available parameters could guide decision-making in multidisciplinary treatment concepts. C-reactive Protein (CRP) is linked to inferior survival in several malignancies. This study assesses CRP within a novel risk score predicting histology and outcome after surgery for sporadic non-functional panNENs. Methods: A retrospective multicenter study with national exploration and international validation. CRP and other factors associated with overall survival (OS) were evaluated by multivariable cox-regression to create a clinical risk score (CRS). Predictive values regarding OS, disease-specific survival (DSS), and recurrence-free survival (RFS) were assessed by time-dependent receiver-operating characteristics. Results: Overall, 364 patients were included. Median CRP was significantly higher in patients >, 60 years, G3, and large tumors. In multivariable analysis, CRP was the strongest preoperative factor for OS in both cohorts. In the combined cohort, CRP (cut-off &ge, 0.2mg/dL, hazard-ratio (HR):3.87), metastases (HR:2.80), and primary tumor size &ge, 3.0cm (HR:1.83) showed a significant association with OS. A CRS incorporating these variables was associated with postoperative histological grading, T category, nodal positivity, and 90-day morbidity/mortality. Time-dependent area-under-the-curve at 60 months for OS, DSS, and RFS was 69%, 77%, and 67%, respectively (all p <, 0.001), and the inclusion of grading further improved the predictive potential (75%, 84%, and 78%, respectively). Conclusions: CRP is a significant marker of unfavorable oncological characteristics in panNENs. The proposed internationally validated CRS predicts histological features and patient survival.
- Published
- 2020
28. A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors
- Author
-
Anneke P. J. Jilesen, S. van Eeden, F. J. van Kemenade, Stefano Partelli, Francesca Muffatti, S. van Dieren, Cansu Guney Genc, J. Verheij, E. J. M. Nieveen van Dijkum, Massimo Falconi, C.H.J. van Eijck, Surgery, CCA - Cancer Treatment and Quality of Life, Pathology, APH - Methodology, AGEM - Digestive immunity, Genc, C. G., Jilesen, A. P., Partelli, S., Falconi, M., Muffatti, F., Van Kemenade, F. J., Van Eeden, S., Verheij, J., Van Dieren, S., Van Eijck, C. H. J., and Nieveen Van Dijkum, E. J. M.
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Scoring system ,recurrence ,Non functional ,Neuroendocrine tumors ,Gastroenterology ,nomogram ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Recurrence ,Internal medicine ,medicine ,Recurrent disease ,Humans ,In patient ,Neoplasm Invasiveness ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Neoplasm Grading ,pancreatic neuroendocrine tumors ,Hepatology ,Proportional hazards model ,business.industry ,Retrospective cohort study ,Nomogram ,Middle Aged ,medicine.disease ,Surgery ,Pancreatic Neoplasms ,Nomograms ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,030211 gastroenterology & hepatology ,Female ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Objective: The aim of this study was to predict recurrence in patients with grade 1 or 2 nonfunctioning pancreatic neuroendocrine tumors (NF-pNET) after curative resection. Background: Surgical resection is the preferred treatment for NF-pNET; however, recurrence occurs frequently after curative surgery, worsening prognosis of patients. Methods: Retrospectively, patients with NF-pNET of 3 institutions were included. Patients with distant metastases, hereditary syndromes, or grade 3 tumors were excluded. Local or distant tumor recurrence was scored. Independent predictors for survival and recurrence were identified using Cox-regression analysis. The recurrence score was developed to predict recurrence within 5 years after curative resection of grade 1 to 2 NF-pNET. Results: With a median follow-up of 51 months, 211 patients with grade 1 to 2 NF-pNET were included. Thirty-five patients (17%) developed recurrence. The 5- and 10-year disease-specific/overall survival was 98%/91% and 84%/68%, respectively. Predictors for recurrence were tumor grade 2, lymph node metastasis, and perineural invasion. On the basis of these predictors, the recurrence score was made. Discrimination [c-statistic 0.81, 95% confidence interval (95% CI) 0.75-0.87] and calibration (Hosmer Lemeshow Chi-square 11.25, P = 0.258) indicated that the ability of the recurrence score to identify patients at risk for recurrence is good. Conclusions: This new scoring system could predict recurrence after curative resection of grade 1 and 2 NF-pNET. With the use of the recurrence score, less extensive follow-up could be proposed for patients with low recurrence risk. For high-risk patients, clinical trials should be initiated to investigate whether adjuvant therapy might be beneficial. External validation is ongoing due to limited availability of adequate cohorts.
- Published
- 2018
29. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
- Author
-
Claudio Doglioni, Francesca Muffatti, Heinz-Josef Klümpen, E.J.M. Nieveen van Dijkum, S. van Eeden, C.H.J. van Eijck, Stefano Partelli, Massimo Falconi, Cansu Guney Genc, Genc, C. G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klumpen, H. J., van Eijck, C. H. J., Nieveen van Dijkum, E. J. M., Surgery, Pathology, CCA - Imaging and biomarkers, AGEM - Digestive immunity, Oncology, and AGEM - Endocrinology, metabolism and nutrition
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Neuroendocrine tumors ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Pancreatectomy ,Surgical oncology ,Internal medicine ,Biomarkers, Tumor ,Medicine ,Humans ,Neoplasm Invasiveness ,Lymph node ,Survival rate ,Aged ,Retrospective Studies ,business.industry ,Proportional hazards model ,Retrospective cohort study ,Pancreatic Tumors ,Middle Aged ,medicine.disease ,Prognosis ,Pancreatic Neoplasms ,Survival Rate ,Regimen ,Neuroendocrine Tumors ,medicine.anatomical_structure ,Ki-67 Antigen ,Oncology ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,030211 gastroenterology & hepatology ,Surgery ,Female ,Neoplasm Recurrence, Local ,business ,Adjuvant ,Follow-Up Studies - Abstract
Background: Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival after curative resection of panNET. Methods: Patients with resected non-functioning panNET diagnosed between 1992 and 2016 from three institutions were retrospectively analyzed. Patients who had G1 or G2 tumor without distant metastases or hereditary syndromes were included in the study. The patients were re-categorized into Ki67 0–5 and Ki67 6–20%. Cox regression analysis with log-rank testing for recurrence and survival was performed. Results: The study enrolled 241 patients (86%) with Ki67 0–5% and 39 patients (14%) with Ki67 6–20%. Recurrence was seen in 34 patients (14%) with Ki67 0–5% after a median period of 34months and in 16 patients (41%) with Ki67 6–20% after a median period of 16months (p < 0.001). The 5-year recurrence-free and 10-year disease-specific survival periods were respectively 90 and 91% for Ki67 0–5% and respectively 55 and 26% for Ki67 6–20% (p < 0.001). The overall survival period after recurrence was 44.9months, which was comparable between the two groups (p = 0.283). In addition to a Ki67 rate higher than 5%, tumor larger than 4cm and lymph node metastases were independently associated with recurrence. Conclusions: Patients at high risk for recurrence after curative resection of G1 or G2 panNET can be identified by a Ki67 rate higher than 5%. These patients should be more closely monitored postoperatively to detect recurrence early and might benefit from adjuvant treatment. A clear postoperative follow-up regimen is proposed.
- Published
- 2018
30. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
- Author
-
Heidsma CM, van Roessel S, van Dieren S, Engelsman AF, Strobel O, Buechler MW, Schimmack S, Perinel J, Adham M, Deshpande V, Kjaer J, Norlen O, Gill AJ, Samra JS, Mittal A, Hoogwater FJH, Primavesi F, Stättner S, Besselink MG, van Eijck CHJ, and Nieveen van Dijkum EJM
- Subjects
- Humans, Nomograms, Prognosis, Retrospective Studies, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors diagnosis, Neuroendocrine Tumors pathology, Neuroendocrine Tumors surgery, Pancreatic Neoplasms pathology
- Abstract
Background: Despite the low recurrence rate of resected nonfunctional pancreatic neuroendocrine tumors (NF-pNETs), nearly all patients undergo long-term surveillance. A prediction model for recurrence may help select patients for less intensive surveillance or identify patients for adjuvant therapy. The objective of this study was to assess the external validity of a recently published model predicting recurrence within 5 years after surgery for NF-pNET in an international cohort. This prediction model includes tumor grade, lymph node status and perineural invasion as predictors., Methods: Retrospectively, data were collected from 7 international referral centers on patients who underwent resection for a grade 1-2 NF-pNET between 1992 and 2018. Model performance was evaluated by calibration statistics, Harrel's C-statistic, and area under the curve (AUC) of the receiver operating characteristic curve for 5-year recurrence-free survival (RFS). A sub-analysis was performed in pNETs >2 cm. The model was improved to stratify patients into 3 risk groups (low, medium, high) for recurrence., Results: Overall, 342 patients were included in the validation cohort with a 5-year RFS of 83% (95% confidence interval [CI]: 78-88%). Fifty-eight patients (17%) developed a recurrence. Calibration showed an intercept of 0 and a slope of 0.74. The C-statistic was 0.77 (95% CI: 0.70-0.83), and the AUC for the prediction of 5-year RFS was 0.74. The prediction model had a better performance in tumors >2 cm (C-statistic 0.80)., Conclusions: External validity of this prediction model for recurrence after curative surgery for grade 1-2 NF-pNET showed accurate overall performance using 3 easily accessible parameters. This model is available via www.pancreascalculator.com., (© 2021 The Author(s) Published by S. Karger AG, Basel.)
- Published
- 2022
- Full Text
- View/download PDF
31. Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
- Author
-
Kaçmaz E, Slooter MD, Nieveen van Dijkum EJM, Tanis PJ, and Engelsman AF
- Subjects
- Aged, Female, Humans, Indocyanine Green, Lymphatic Metastasis, Male, Middle Aged, Retrospective Studies, Fluorescein Angiography methods, Intestinal Neoplasms diagnostic imaging, Intestinal Neoplasms surgery, Intestine, Small, Neuroendocrine Tumors diagnostic imaging, Neuroendocrine Tumors surgery, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms surgery, Stomach Neoplasms diagnostic imaging, Stomach Neoplasms surgery
- Abstract
Background: Surgery for small bowel neuroendocrine neoplasms (SB-NEN) might result in vascular compromise of the remaining bowel due to resection of lymph node metastases in close proximity to main mesenteric vessels. Fluorescence angiography (FA) has been described as a safe technique to assess perfusion during gastro-intestinal surgery. This study aimed to evaluate the potential value of intraoperative FA during surgery for SB-NEN., Methods: This study included patients undergoing surgery for SB-NEN of any stage. The planned level of transection was marked by the surgeon, after which FA using indocyanine green (ICG) was performed. The primary study outcome was change in management due to FA., Results: Ten consecutive patients with SB-NEN were included, all with metastatic lymph nodes close to main mesenteric vessels. FA use led to management changes in eight patients (80%); four patients had less bowel resected with a preserved length of 5-35 cm. The other four patients had more extended bowel resections with an additional length varying from 3 to 25 cm. The median postoperative stay was 4 days (interquartile range 4-6). No anastomotic leakage occurred., Conclusion: This is the first known series describing preliminary results of FA during SB-NEN surgery. FA led to a management change in 80% of patients with better tailoring the extent of resection of small bowel. Structural implementation of FA to assess small bowel perfusion after dissection for small bowel NET results in change of management, either by preserving small bowel or resecting ill-perfused small bowel., Competing Interests: Declaration of competing interest The authors have no conflicts of interest to disclose., (Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
32. Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.
- Author
-
Jonker LA, Lebbink CA, Jongmans MCJ, Nievelstein RAJ, Merks JHM, Nieveen van Dijkum EJM, Links TP, Hoogerbrugge N, van Trotsenburg ASP, and van Santen HM
- Abstract
Background: PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in the PTEN gene. Children with a germline PTEN mutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guidelines have focused on thyroid surveillance in these children, but studies substantiating these recommendations are lacking., Objective: The present study intends to provide the available evidence for a thyroid carcinoma surveillance program in children with PHTS., Methods: An extensive literature search was performed to identify all studies on DTC in pediatric PHTS patients. Two pediatric cases are presented to illustrate the pros and cons of thyroid carcinoma surveillance. Recommendations for other patient groups at risk for DTC were evaluated. Consensus within the study team on recommendations for children with PHTS was reached by balancing the incidence and behavior of DTC with the pros and cons of thyroid surveillance, and the different surveillance methods., Results: In 5 cohort studies the incidence of DTC in childhood ranged from 4 to 12%. In total 57 cases of DTC and/or benign nodular disease in pediatric PHTS patients were identified, of which 27 had proven DTC, with a median age of 12 years (range 4-17). Follicular thyroid carcinoma (FTC) was diagnosed in 52% of the pediatric DTC patients. No evidence was found for a different clinical behavior of DTC in PHTS patients compared to sporadic DTC., Conclusions: Children with PHTS are at increased risk for developing DTC, with 4 years being the youngest age reported at presentation and FTC being overrepresented. DTC in pediatric PHTS patients does not seem to be more aggressive than sporadic DTC., Recommendations: Surveillance for DTC in pediatric PHTS patients seems justified, as early diagnosis may decrease morbidity. Consensus within the study team was reached to recommend surveillance from the age of 10 years onwards, since at that age the incidence of DTC seems to reach 5%. Surveillance for DTC should consist of yearly neck palpation and triennial thyroid ultrasound. Surveillance in children with PHTS should be performed in a center of excellence for pediatric thyroid disease or PHTS., Competing Interests: The authors have nothing to disclose., (Copyright © 2020 by S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
33. Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head.
- Author
-
Kaçmaz E, Zwart MJW, Engelsman AF, Busch OR, Nieveen van Dijkum EJM, and Besselink MG
- Subjects
- Adult, Dissection, Female, Humans, Insulinoma diagnostic imaging, Insulinoma pathology, Pancreatectomy, Pancreatic Ducts surgery, Pancreatic Neoplasms pathology, Prospective Studies, Treatment Outcome, Insulinoma surgery, Pancreas surgery, Pancreatic Neoplasms surgery, Robotic Surgical Procedures
- Abstract
Pancreatic parenchyma sparing surgery for insulinomas avoids the risk of endocrine and exocrine insufficiency, and potential high-risk anastomoses associated with pancreatic resection. Robotic surgery may be used as an alternative for open pancreatic enucleation without compromising dexterity and 3D-vision. We present the case of a 42-year old woman who presented with sweating, tremor and episodes of hypoglycemia. A fasting test confirmed endogenic insulin overproduction. After inconclusive CT- and MRI imaging, endoscopic ultrasonography showed a hypoechoic lesion, which was fully within the pancreatic head. Although consent was obtained for pancreatoduodenectomy, robotic enucleation seemed feasible. After mobilization, intraoperative ultrasonography was used to identify the lesion and its relation with the pancreatic duct. Dissection was performed using a traction suture, hot shears and bipolar diathermia. A sealant patch was applied for hemostasis and a drain placed. The patient developed a grade B pancreatic fistula for which endoscopic sphincterotomy was performed; the surgical drain could be removed in the outpatient clinic after 20 days. Prospective studies should confirm the short- and long-term benefits of robotic enucleation of insulinomas.
- Published
- 2020
- Full Text
- View/download PDF
34. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.
- Author
-
Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, Nieveen van Dijkum EJM, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, and van Santen HM
- Subjects
- Early Detection of Cancer methods, Humans, Survivors, Neoplasms radiotherapy, Radiation Exposure adverse effects, Thyroid Gland radiation effects, Thyroid Neoplasms etiology
- Abstract
Radiation exposure to the thyroid gland during treatment of childhood, adolescent and young adult cancer (CAYAC) may cause differentiated thyroid cancer (DTC). Surveillance recommendations for DTC vary considerably, causing uncertainty about optimum screening practices. The International Late Effects of Childhood Cancer Guideline Harmonization Group, in collaboration with the PanCareSurFup Consortium, developed consensus recommendations for thyroid cancer surveillance in CAYAC survivors. These recommendations were developed by an international multidisciplinary panel that included 33 experts in relevant medical specialties who used a consistent and transparent process. Recommendations were graded according to the strength of underlying evidence and potential benefit gained by early detection and appropriate management. Of the two available surveillance strategies, thyroid ultrasound and neck palpation, neither was shown to be superior. Consequently, a decision aid was formulated to guide the health care provider in counseling the survivor. The recommendations highlight the need for shared decision making regarding whether to undergo surveillance for DTC and in the choice of surveillance modality., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
35. [Intraoperative neuromonitoring in endocrine surgery: when is it appropriate?]
- Author
-
Engelsman AF and Nieveen van Dijkum EJM
- Subjects
- Humans, Postoperative Complications etiology, Recurrent Laryngeal Nerve surgery, Recurrent Laryngeal Nerve Injuries etiology, Thyroidectomy adverse effects, Thyroidectomy methods, Vocal Cord Paralysis etiology, Intraoperative Neurophysiological Monitoring methods, Postoperative Complications prevention & control, Recurrent Laryngeal Nerve Injuries prevention & control, Thyroid Gland surgery, Vocal Cord Paralysis prevention & control
- Abstract
The use of intraoperative neuromonitoring (IONM) in thyroid surgery has steadily increased in recent years. This technique helps to identify different nerves in and around the operation site, such as the recurrent laryngeal nerve (RLN) and the external branch of the superior laryngeal nerve. Particularly in patients who undergo a second operation or a complex procedure for malignancy, the technique's value has been demonstrated. However, in non-complex thyroid operations the risk of vocal cord paresis due to iatrogenic injury of the RLN is 0.1%. Therefore, high quality research with sufficient power to assess the effect of IONM on prevention of vocal cord paresis is scarce, and the routine use of IONM in thyroid surgery is currently not indicated.
- Published
- 2018
36. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
- Author
-
Jilesen AP, Hoefnagel SJ, Busch OR, Bennink RJ, Gouma DJ, and Nieveen van Dijkum EJ
- Subjects
- Female, Humans, Male, Middle Aged, Neoplasm Staging, Neuroendocrine Tumors secondary, Preoperative Care methods, Radiopharmaceuticals pharmacokinetics, Reproducibility of Results, Sensitivity and Specificity, Somatostatin analogs & derivatives, Somatostatin pharmacokinetics, Tomography, Emission-Computed, Single-Photon methods, Tomography, X-Ray Computed methods, Neuroendocrine Tumors diagnostic imaging, Neuroendocrine Tumors metabolism, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms metabolism, Pancreatic Neoplasms secondary, Receptors, Somatostatin metabolism
- Abstract
Aim: To determine whether somatostatin receptor scintigraphy (SRS) influences the preoperative staging and clinical management of non-functioning pancreatic neuroendocrine tumours (NF-pNETs)., Materials and Methods: All SRS examinations performed between 2002-2013 were selected. Patients with NF-pNET were included if both computed tomography (CT) and SRS was performed during preoperative staging. The diagnostic accuracy of CT and SRS for detecting NF-pNET metastases was analysed. Altered TNM classification and changed clinical management were calculated. Changed management was defined as a change from surgical resection into systemic treatment or vice versa. NF-pNETs were defined as tumours without clinical symptoms of hormonal hypersecretion., Results: Overall, 62 patients with NF-pNET were included with a mean age of 57 years (SD: 12.4)(2). In 28 patients (45%), CT and SRS were correct and in agreement in the detection of primary tumour/metastases. In 34 patients (55%), one of the techniques was incorrect and therefore, there was no agreement. SRS altered the TNM classification in 14 patients (23%) and clinical management in nine patients (15%). In patients without metastases on CT, SRS detected lymph node metastases in one patient. The sensitivity to detect the primary tumour with CT was 95% and with SRS was 73%. In detecting metastases, the sensitivity and specificity were both 85% for CT versus 80% and 90% for SRS., Conclusion: Overall, CT and SRS were in agreement in the detection of NF-pNET. In NF-pNET without suspicious metastatic lesions on CT, SRS has limited value. SRS may be indicated to confirm lesions suspicious for neuroendocrine tumours metastases., (Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.
- Author
-
Clement SC, Peeters RP, Ronckers CM, Links TP, van den Heuvel-Eibrink MM, Nieveen van Dijkum EJ, van Rijn RR, van der Pal HJ, Neggers SJ, Kremer LC, van Eck-Smit BL, and van Santen HM
- Subjects
- Female, Gonadal Disorders etiology, Humans, Lacrimal Apparatus, Male, Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Carcinoma radiotherapy, Eye Diseases etiology, Infertility, Female etiology, Iodine Radioisotopes adverse effects, Oligospermia etiology, Salivary Gland Diseases etiology, Thyroid Neoplasms radiotherapy
- Abstract
Background: Treatment of differentiated thyroid carcinoma (DTC) often involves administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC has favorable outcome and the incidence is increasing, concerns have been raised about the possible adverse effects of I-131 therapy. We systematically reviewed the literature to examine the risk of intermediate and long-term adverse effects of I-131 therapy in DTC patients., Methods: Multiple electronic databases were searched up to November 2014 for English-language, controlled studies that reported on the risk of salivary gland dysfunction, lacrimal gland dysfunction, gonadal dysfunction, female reproductive outcomes or second primary malignancies (SPM) after I-131 exposure. The certainty of the evidence found was assessed using GRADE., Results: In total, 37 articles met all inclusion criteria, no studies reporting on adverse effects after I-131 treatment focused solely on children. After exposure to I-131 for DTC, patients experienced significantly more frequently salivary gland dysfunction (prevalence range: 16-54%, moderate-level evidence), lacrimal gland dysfunction (prevalence: 11%, low-level evidence), transient male gonadal dysfunction (prevalence: 35-100%, high-level evidence), transient female gonadal dysfunction (prevalence: 28%, low-level evidence) and SPM (prevalence: 2.7-8.7%, moderate-level evidence) compared to unexposed patients. I-131 therapy seems to have no deleterious effects on female reproductive outcomes (very-low level evidence). The prevalence and severity of adverse effects were correlated to increasing cumulative I-131 activity., Conclusion: Treatment with I-131 for DTC may have significant adverse effects, which seem to be dose dependent. These adverse effects of treatment must be balanced when choosing for I-131 therapy in patients with DTC., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
38. An adrenal incidentaloma: how often is it detected and what are the consequences?
- Author
-
Minnaar EM, Human KE, Henneman D, Nio CY, Bisschop PH, and Nieveen van Dijkum EJ
- Abstract
Objectives. The aim of this study was to investigate the detection rate of adrenal incidentalomas and subsequent workup. Design. Retrospective cohort study. Methods. Two investigators evaluated the adrenals on abdominal CT scans. Abnormalities were compared to the original radiology reports and an experienced abdominal radiologist reviewed the CT scans. All additional imaging and laboratory tests were assessed. Results. The investigators detected 44/356 adrenal incidentalomas (12%). In 25 patients an adrenal incidentaloma had been noted in the radiology report. The expert radiologist agreed on 19 incidentalomas in 17 patients, two with bilateral incidentalomas. Of the 25 incidentaloma patients, 4 (16%) patients were screened for hormonal overproduction and 2 (8%) patients had follow-up imaging studies. Conclusions. 12% of the patients had an adrenal incidentaloma (42 of 356). 17 (40%) had initially not been reported by the radiologist. When diagnosed with an adrenal incidentaloma, only a small percentage of patients (16%) is screened or undergoes repeated imaging (8%) as proposed in the National Institutes of Health (NIH) guidelines on adrenal incidentalomas.
- Published
- 2012
- Full Text
- View/download PDF
39. Vitamin D, or wait and see?
- Author
-
Wentholt IM, Bras J, Kroon FH, Nieveen van Dijkum EJ, and Fliers E
- Subjects
- Humans, Vitamin D
- Published
- 2012
40. Secondary hyperparathyroidism: Uncommon cause of a leg ulcer.
- Author
-
van Rijssen LB, Brenninkmeijer EE, and Nieveen van Dijkum EJ
- Abstract
Introduction: Most leg ulcers are vascular based. Only if vascular therapy fails other causes are considered. We report the case of a female with incapacitating leg ulcers caused by a rare condition which was only diagnosed after failing treatment., Presentation of Case: The female had an extensive previous history including diabetes, renal insufficiency and cardiovascular disease and presented with three large and painful ulcers on her left lower leg. Standard treatment with antibiotics, wound excision and additional treatment with hyperbaric oxygen were ineffective. One month post hospital-admission calciphylaxis cutis caused by renal failure induced secondary hyperparathyroidism was diagnosed. Surgical treatment by a parathyroidectomy induced rapid regeneration of the ulcers., Discussion: Our patient's vast comorbidity and previous history had expanded differential considerations causing a delay in diagnosis. Our patient's previous history led us to believe her ulcers were vascular based, however her chronic renal failure appeared responsible for her condition., Conclusion: Although less probable than venous insufficiency and concomittant leg ulcers or other differential considerations, calciphylaxis cutis should be part of the differential diagnosis in any end stage renal disease-patient with unexplained ulcers as an effective therapy is readily available.
- Published
- 2012
- Full Text
- View/download PDF
41. [Pain in the throat due to acute suppurative thyroiditis caused by Salmonella].
- Author
-
van Bon AC, Krudop W, van Eeden S, Schreuder MC, Nieveen van Dijkum EJ, Fliers E, and Wiersinga WM
- Subjects
- Female, Humans, Middle Aged, Salmonella Infections drug therapy, Salmonella Infections surgery, Thyroidectomy methods, Thyroiditis, Suppurative drug therapy, Thyroiditis, Suppurative microbiology, Thyroiditis, Suppurative surgery, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Salmonella Infections diagnosis, Thyroiditis, Suppurative diagnosis
- Abstract
A 53-year-old woman presented with fever accompanied by chills and an extremely painful swelling of her right thyroid lobe. She was initially diagnosed as having subacute thyroiditis, but after 14 days her disease appeared to be caused by a destructive suppurative thyroiditis due to Salmonella group C. A pre-existing hyperplastic nodule in the right thyroid lobe was the predisposing factor. Antibiotics were given for several weeks and surgical drainage was performed. Finally a hemithyroidectomy was done to eliminate the predisposing factor.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.